BB vs RLMD · P/E 117, rev $549.1M vs $692.3M cap
BlackBerry Ltd (BB) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
RLMD does not have a complete income-statement cache yet.
BB currently screens at market cap $6.14B and trailing P/E 116.5. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the BB and RLMD stock pages for the full models.
Not investment advice.